Alopecia-epilepsy-pyorrhea-intellectual disability syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1008OMIM:104130Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Alopecia-epilepsy-pyorrhea-intellectual disability syndrome (also known as Shokeir syndrome) is an extremely rare genetic disorder characterized by the combination of four cardinal features: alopecia (hair loss), epilepsy (seizures), pyorrhea (severe periodontal disease with purulent inflammation of the gums and supporting structures of the teeth), and intellectual disability. The condition affects multiple body systems including the integumentary system (skin and hair), the central nervous system (brain), the oral cavity (teeth and gums), and cognitive development. Hair loss may be total or near-total, and the periodontal disease can lead to premature loss of teeth. Seizures may vary in type and severity, and intellectual disability ranges from mild to severe. This syndrome was originally described in a small number of affected families. Due to its extreme rarity, the clinical spectrum and natural history of the condition remain incompletely characterized. There is no specific cure or targeted therapy for this syndrome. Management is supportive and symptom-based, involving antiepileptic medications for seizure control, dental and periodontal care to manage pyorrhea and preserve oral health as long as possible, dermatological evaluation for alopecia, and educational and developmental support services for intellectual disability. A multidisciplinary approach involving neurologists, dentists, dermatologists, and developmental specialists is recommended for optimal patient care.

Also known as:

Clinical phenotype terms— hover any for plain English:

PeriodontitisHP:0000704Alopecia universalisHP:0002289
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Alopecia-epilepsy-pyorrhea-intellectual disability syndrome.

View clinical trials →

No actively recruiting trials found for Alopecia-epilepsy-pyorrhea-intellectual disability syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Alopecia-epilepsy-pyorrhea-intellectual disability syndrome community →

No specialists are currently listed for Alopecia-epilepsy-pyorrhea-intellectual disability syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Alopecia-epilepsy-pyorrhea-intellectual disability syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Alopecia-epilepsy-pyorrhea-intellectual disability syndromeForum →

No community posts yet. Be the first to share your experience with Alopecia-epilepsy-pyorrhea-intellectual disability syndrome.

Start the conversation →

Latest news about Alopecia-epilepsy-pyorrhea-intellectual disability syndrome

No recent news articles for Alopecia-epilepsy-pyorrhea-intellectual disability syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Alopecia-epilepsy-pyorrhea-intellectual disability syndrome

What is Alopecia-epilepsy-pyorrhea-intellectual disability syndrome?

Alopecia-epilepsy-pyorrhea-intellectual disability syndrome (also known as Shokeir syndrome) is an extremely rare genetic disorder characterized by the combination of four cardinal features: alopecia (hair loss), epilepsy (seizures), pyorrhea (severe periodontal disease with purulent inflammation of the gums and supporting structures of the teeth), and intellectual disability. The condition affects multiple body systems including the integumentary system (skin and hair), the central nervous system (brain), the oral cavity (teeth and gums), and cognitive development. Hair loss may be total or n

How is Alopecia-epilepsy-pyorrhea-intellectual disability syndrome inherited?

Alopecia-epilepsy-pyorrhea-intellectual disability syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Alopecia-epilepsy-pyorrhea-intellectual disability syndrome typically begin?

Typical onset of Alopecia-epilepsy-pyorrhea-intellectual disability syndrome is childhood. Age of onset can vary across affected individuals.